These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 19517477)

  • 41. Evaluation of a breast cancer nomogram for predicting the likelihood of additional nodal metastases in patients with a positive sentinel node biopsy.
    Scomersi S; Torelli L; Zanconati F; Tonutti M; Dore F; Bortul M
    Ann Ital Chir; 2012; 83(6):461-8. PubMed ID: 23110902
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Risk factors of non-sentinel lymph node metastasis and performance of MSKCC nomogramin breast cancer patients with metastatic sentinel lymph node].
    Huang J; Chen X; Fei X; Huang O; Wu J; Zong Y; Zhu L; He J; Chen W; Li Y; Shen K
    Zhonghua Wai Ke Za Zhi; 2015 Dec; 53(12):941-6. PubMed ID: 26850667
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prediction of nonsentinel lymph node involvement in patients with a positive sentinel lymph node in malignant melanoma.
    Page AJ; Carlson GW; Delman KA; Murray D; Hestley A; Cohen C
    Am Surg; 2007 Jul; 73(7):674-8; discussion 678-9. PubMed ID: 17674939
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A new model for predicting non-sentinel lymph node status in Chinese sentinel lymph node positive breast cancer patients.
    Liu M; Wang S; Pan L; Yang D; Xie F; Liu P; Guo J; Zhang J; Zhou B
    PLoS One; 2014; 9(8):e104117. PubMed ID: 25111296
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A scoring system to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a comparison with other scoring systems.
    Cho J; Han W; Lee JW; Ko E; Kang SY; Jung SY; Kim EK; Moon WK; Cho N; Park IA; Chung JK; Hwang KT; Kim SW; Noh DY
    Ann Surg Oncol; 2008 Aug; 15(8):2278-86. PubMed ID: 18528729
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Simple prediction models for breast cancer patients with solitary positive sentinel nodes--are they valid?
    Scow JS; Degnim AC; Hoskin TL; Reynolds C; Boughey JC
    Breast J; 2009; 15(6):610-4. PubMed ID: 19824998
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The likelihood of additional nodal disease following a positive sentinel lymph node biopsy in breast cancer patients: validation of a nomogram.
    Cripe MH; Beran LC; Liang WC; Sickle-Santanello BJ
    Am J Surg; 2006 Oct; 192(4):484-7. PubMed ID: 16978955
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predicting non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement: evaluation of two scoring systems.
    Sanjuán A; Escaramís G; Vidal-Sicart S; Illa M; Zanón G; Pahisa J; Rubí S; Velasco M; Santamaría G; Farrús B; Muñoz M; García Y; Fernández PL; Pons F
    Breast J; 2010; 16(2):134-40. PubMed ID: 20136644
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Do micromorphometric features of metastatic deposits within sentinel nodes predict nonsentinel lymph node involvement in melanoma?
    Frankel TL; Griffith KA; Lowe L; Wong SL; Bichakjian CK; Chang AE; Cimmino VM; Bradford CR; Rees RS; Johnson TM; Sabel MS
    Ann Surg Oncol; 2008 Sep; 15(9):2403-11. PubMed ID: 18626721
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Validation of a scoring system to predict non-sentinel lymph node metastasis in melanoma.
    Cadili A; McKinnon G; Wright F; Hanna W; Macintosh E; Abhari Z; Dabbs K
    J Surg Oncol; 2010 Mar; 101(3):191-4. PubMed ID: 20039281
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Comparison of three models to predict non-sentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a retrospective study of 77 patients].
    Terrier C; Tariel O; Coutant C; De Saint Hilaire P; Devouassoux M; Rudigoz RC; Dubernard G
    J Gynecol Obstet Biol Reprod (Paris); 2012 May; 41(3):227-34. PubMed ID: 22464015
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An independent assessment of the 7 nomograms for predicting the probability of additional axillary nodal metastases after positive sentinel lymph node biopsy in a cohort of British patients with breast cancer.
    Nadeem RM; Gudur LD; Saidan ZA
    Clin Breast Cancer; 2014 Aug; 14(4):272-9. PubMed ID: 25037530
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use and limitations of a nomogram predicting the likelihood of non-sentinel node involvement after a positive sentinel node biopsy in breast cancer patients.
    Kocsis L; Svébis M; Boross G; Sinkó M; Maráz R; Rajtár M; Cserni G
    Am Surg; 2004 Nov; 70(11):1019-24. PubMed ID: 15586519
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessment of an existing and modified model for predicting non sentinel lymph node metastasis in breast cancer patients with positive sentinel node biopsy.
    Al-Masri M; Darwazeh G; El-Ghanem M; Hamdan B; Sughayer M
    Gulf J Oncolog; 2013 Jan; 1(13):15-22. PubMed ID: 23339977
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma.
    Sabel MS; Griffith K; Sondak VK; Lowe L; Schwartz JL; Cimmino VM; Chang AE; Rees RS; Bradford CR; Johnson TM
    J Am Coll Surg; 2005 Jul; 201(1):37-47. PubMed ID: 15978442
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer.
    Katz A; Smith BL; Golshan M; Niemierko A; Kobayashi W; Raad RA; Kelada A; Rizk L; Wong JS; Bellon JR; Gadd M; Specht M; Taghian AG
    J Clin Oncol; 2008 May; 26(13):2093-8. PubMed ID: 18445838
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Validation of a nomogram to predict the presence of sentinel lymph node metastases in melanoma.
    Piñero A; Canteras M; Ortiz E; Martínez-Barba E; Parrilla P
    Ann Surg Oncol; 2008 Oct; 15(10):2874-7. PubMed ID: 18648880
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Validation of online calculators to predict the non-sentinel lymph node status in sentinel lymph node-positive breast cancer patients.
    Tanaka S; Sato N; Fujioka H; Takahashi Y; Kimura K; Iwamoto M
    Surg Today; 2013 Feb; 43(2):163-70. PubMed ID: 22722328
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prediction of non-sentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node.
    Reynders A; Brouckaert O; Smeets A; Laenen A; Yoshihara E; Persyn F; Floris G; Leunen K; Amant F; Soens J; Van Ongeval C; Moerman P; Vergote I; Christiaens MR; Staelens G; Van Eygen K; Vanneste A; Van Dam P; Colpaert C; Neven P
    Breast; 2014 Aug; 23(4):453-9. PubMed ID: 24768478
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients.
    Roka F; Mastan P; Binder M; Okamoto I; Mittlboeck M; Horvat R; Pehamberger H; Diem E
    Eur J Surg Oncol; 2008 Jan; 34(1):82-8. PubMed ID: 17360144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.